Published in Crit Care Med on January 01, 2016
Delayed awakening after cardiac arrest: prevalence and risk factors in the Parisian registry. Intensive Care Med (2016) 0.84
Fentanyl Pharmacokinetics in Critically Ill Patients: A Demonstration of Mixed Effects. Crit Care Med (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med (1996) 35.00
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
The path to personalized medicine. N Engl J Med (2010) 9.87
Long-term cognitive impairment after critical illness. N Engl J Med (2013) 9.20
Prediction error estimation: a comparison of resampling methods. Bioinformatics (2005) 6.41
Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med (2012) 5.15
Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology (2007) 2.83
Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology (1990) 1.44
Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther (1987) 1.28
Intravenous fentanyl kinetics. Clin Pharmacol Ther (1980) 1.25
Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs (2012) 1.06
Anesthesia in the obese patient: pharmacokinetic considerations. J Clin Anesth (2005) 0.99
Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos (1996) 0.99
Comparative pharmacokinetics of fentanyl and alfentanil. Br J Anaesth (1982) 0.96
Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. Br J Clin Pharmacol (2004) 0.94
Opioids and renal function. J Pain (2004) 0.93
Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II). Clin Pharmacokinet (1991) 0.90
Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass"). Anesthesiology (2004) 0.90
Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. J Anal Toxicol (2011) 0.90
Population pharmacokinetics of dexmedetomidine in critically ill patients. Clin Drug Investig (2013) 0.89
CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol (2012) 0.88
The use of major analgesics in patients with renal dysfunction. Curr Drug Targets (2010) 0.87
The population pharmacokinetics of fentanyl in patients undergoing living-donor liver transplantation. Clin Pharmacol Ther (2011) 0.86
A Bayesian hierarchical nonlinear mixture model in the presence of artifactual outliers in a population pharmacokinetic study. J Pharmacokinet Pharmacodyn (2011) 0.86
Pharmacokinetics of propofol during and after long-term continuous infusion for maintenance of sedation in ICU patients. Br J Anaesth (1992) 0.86
Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. Br J Anaesth (1982) 0.85
Pharmacokinetics of fentanyl in the elderly. Br J Anaesth (1988) 0.83
Urine drug testing of chronic pain patients. III. Normetabolites as biomarkers of synthetic opioid use. J Anal Toxicol (2010) 0.82
Population pharmacokinetics of fentanyl in healthy volunteers. J Clin Pharmacol (2001) 0.80
Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns. Burns (2009) 0.78
Validation of fentanyl pharmacokinetics in patients undergoing coronary artery bypass grafting. Can J Anaesth (2002) 0.78
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA (2010) 10.82
Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA (2009) 10.24
Azithromycin and the risk of cardiovascular death. N Engl J Med (2012) 8.18
Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med (2009) 7.89
Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13
Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med (2004) 6.21
Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study. Lancet (2002) 5.17
Costs associated with delirium in mechanically ventilated patients. Crit Care Med (2004) 4.75
Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med (2010) 4.69
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58
New drugs for rheumatoid arthritis. N Engl J Med (2004) 4.38
Delirium in the cardiovascular ICU: exploring modifiable risk factors. Crit Care Med (2013) 4.34
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med (2003) 4.04
Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology (2006) 4.03
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose. Blood (2008) 4.02
Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle. Crit Care Med (2014) 3.46
Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med (2010) 3.32
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum (2005) 3.17
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10
Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med (2009) 2.96
Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med (2010) 2.90
Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med (2010) 2.86
Six-month neuropsychological outcome of medical intensive care unit patients. Crit Care Med (2003) 2.83
Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med (2009) 2.77
Findings on the portable chest radiograph correlate with fluid balance in critically ill patients. Chest (2002) 2.77
Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers. Crit Care Med (2005) 2.72
The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev (2004) 2.72
Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med (2011) 2.59
Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care (2005) 2.53
Delirium in the intensive care unit: occurrence and clinical course in older patients. J Am Geriatr Soc (2003) 2.53
Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc (2006) 2.49
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet (2002) 2.49
Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma (2008) 2.46
Poststroke delirium incidence and outcomes: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med (2012) 2.34
Delirium in the intensive care unit. Crit Care (2008) 2.34
Reducing iatrogenic risks: ICU-acquired delirium and weakness--crossing the quality chasm. Chest (2010) 2.28
The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med (2004) 2.24
Atypical sleep in ventilated patients: empirical electroencephalography findings and the path toward revised ICU sleep scoring criteria. Crit Care Med (2013) 2.20
Reform of drug regulation--beyond an independent drug-safety board. N Engl J Med (2006) 2.17
Blacks have a greater sensitivity to α1-adrenoceptor-mediated venoconstriction compared with whites. Hypertension (2013) 2.13
Validity of a Modified Sequential Organ Failure Assessment Score Using the Richmond Agitation-Sedation Scale. Crit Care Med (2016) 2.10
Derivation and validation of Spo2/Fio2 ratio to impute for Pao2/Fio2 ratio in the respiratory component of the Sequential Organ Failure Assessment score. Crit Care Med (2009) 2.02
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis (2006) 2.00
Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy. Blood (2008) 1.99
Delirium in the ICU and subsequent long-term disability among survivors of mechanical ventilation. Crit Care Med (2014) 1.98
Chronic conditions among children admitted to U.S. pediatric intensive care units: their prevalence and impact on risk for mortality and prolonged length of stay*. Crit Care Med (2012) 1.97
Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care (2010) 1.97
The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study*. Crit Care Med (2012) 1.97
A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf (2010) 1.97
The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study*. Crit Care Med (2012) 1.96
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95
Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes. Acad Emerg Med (2009) 1.95
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes (2009) 1.90
Cognitive and physical rehabilitation of intensive care unit survivors: results of the RETURN randomized controlled pilot investigation. Crit Care Med (2012) 1.90
Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med (2007) 1.89
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab (2014) 1.88
CYP2C9 allelic variants: ethnic distribution and functional significance. Adv Drug Deliv Rev (2002) 1.86
The aprotinin story--is BART the final chapter? N Engl J Med (2008) 1.84
Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up. Am J Respir Crit Care Med (2013) 1.83
Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology (2007) 1.80
Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arthritis Rheum (2005) 1.80
Effectiveness of medical resident education in mechanical ventilation. Am J Respir Crit Care Med (2002) 1.79
Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood (2011) 1.77
Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology (2013) 1.75
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial. Am J Respir Crit Care Med (2010) 1.70
Motoric subtypes of delirium in mechanically ventilated surgical and trauma intensive care unit patients. Intensive Care Med (2007) 1.69
The Preschool Confusion Assessment Method for the ICU: Valid and Reliable Delirium Monitoring for Critically Ill Infants and Children. Crit Care Med (2016) 1.69
Intracerebral hemorrhage and delirium symptoms. Length of stay, function, and quality of life in a 114-patient cohort. Am J Respir Crit Care Med (2013) 1.68
Short-term outcomes in older intensive care unit patients with dementia. Crit Care Med (2005) 1.65
The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative. Am J Respir Crit Care Med (2015) 1.64
Monitoring delirium in critically ill patients. Using the confusion assessment method for the intensive care unit. Crit Care Nurse (2003) 1.63
Sedation, delirium and mechanical ventilation: the 'ABCDE' approach. Curr Opin Crit Care (2011) 1.63
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63